You are here

Article Text

Article menu

Download PDFPDF

Letter to the editor
Response to ‘Safety issue with TT380 Slimline intrauterine contraceptive device’
Free
  1. Colin G Parker1
  1. Durbin plc, Harrow, London, UK; c.parker@durbin.co.uk
  1. ↵Correspondence to Dr Colin G Parker; c.parker{at}durbin.co.uk

https://doi.org/10.1136/jfprhc-2017-101826

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    I write as the UK distributor for the TT380 Slimline IUD produced by Laboratoire 7 Med of France in response to Dr Trewinnard’s letter.1

    We were sorry to hear of this unfortunate incident. Over the years we have had isolated examples of this occurring, particularly with a retroverted uterus. Extensive investigation revealed that one step in the post-sterilisation final packing process could result in a slight compression of the introducer tube of a tiny proportion of a production batch.

    The process was changed and this seemed to reduce the already low incidence of ‘kinking’.

    Moreover, as part of the continuous improvement of the device, a redesigned version will be available for evaluation early in June which should reduce these occurrences even further.

    I shall ensure that Dr Trewinnard receives one of the evaluation samples as soon as they arrive.

    Reference

    1. ↵
      2. Trewinnard K
      . Safety issue with TT380 Slimline intrauterine contraceptive device. J Fam Plann Reprod Health Care 2017;43.

    Footnotes

    • Competing interests The author is an employee of Durbin PLC.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles